Heliodermatitis
Start Here:
Before using SmartLotion®, you must read this disclaimer.
We recommend reading these general instructions on how to use SmartLotion®: Click here.
Stinging can occur when first applying SmartLotion®. For instructions on how to reduce the stinging, please click here.
Symptoms:
Chronic sun damage that stays red, rough or scaly. Inflamed, sun damaged skin can be either heliodermatitis by itself or seborrheic dermatitis mixed in with sun damage skin.
Recovery:
Dr. Harlan typically treats his adult patients for these symptoms by having them apply SmartLotion® 2x per day for up to 2 weeks.
As long as the patient sees improvement during the initial 2 weeks, after 2 weeks he typically recommends tapering down to 1x per day for 2 weeks. The rate of tapering should vary based on how quickly the rash is healing.
If the patient does not see improvement within the first 2 weeks, he will prescribe them a stronger treatment for 3 weeks to help with initial control and recovery before switching back to SmartLotion®.
Whenever Dr. Harlan has a patient with sun damaged skin, he performs a skin cancer check. He recommends that anyone who sees their dermatologist about potential heliodermatitis issues has them perform a skin cancer check as well.
Prevention:
Dr. Harlan tells his adult patients to maintain a routine of 1x per day SmartLotion® applications or less as needed.
He recommends that all patients with sun damaged skin always wear sunblock with a minimum SPF of 30.
Some patients require intervals of 2x and 1x every other day SmartLotion® applications for complete flare-up control. Some patients require 1 application per day, and some only require 3 applications per week.
This is why long-term safety was so important to Dr. Harlan when he formulated SmartLotion®. For whatever maintenance schedule his patients require, he wanted to ensure that there would be no chance of side effects. Rest assured, SmartLotion® is 100% safe for long term use, as demonstrated in his peer-reviewed safety study.
To read Dr. Harlan's peer -reviewed safety study, please click here.
